Reverse left ventricular (LV) remodeling and recovery of LV function are associated with
improved clinical outcomes in patients with heart failure with reduced ejection fraction. A …

Background A subset of patients with heart failure (HF) and preserved left ventricular
ejection fraction (EF) previously had EF< 40%. We postulated that such “recovered” EF …

Aims Significant recovery of left ventricular ejection fraction (LVEF) occurs in a proportion of
patients with heart failure (HF) and reduced ejection fraction (HFrEF). We analysed …

Heart failure with preserved ejection fraction (HFpEF) is a common clinical syndrome
associated with high rates of morbidity and mortality. Due to the lack of evidence-based …

Approximately half of all patients with heart failure have preserved ejection fraction (HFpEF)
and, as life expectancies continue to increase in western societies, the prevalence of HFpEF …

In contrast to the wealth of proven therapies for heart failure with reduced ejection fraction
(HFrEF), therapeutic efforts in the past have failed to improve outcomes in heart failure with …

The 2016 European Society of Cardiology heart failure guidelines introduced the term 'heart
failure with mid‐range ejection fraction'(HFmrEF) to refer to patients with heart failure and a …

Heart failure (HF) is a clinical syndrome of diverse etiologies and can be associated with
preserved, reduced, or mid-range ejection fraction (EF). In the community, heart failure with …

It is estimated that half of all patients with heart failure (HF) have HF with preserved ejection
fraction (HFpEF). Yet this form of HF remains a diagnostic and therapeutic challenge …

Background—We hypothesized that patients with heart failure (HF) who recover left
ventricular function (HF-Recovered) have a distinct clinical phenotype, biology, and …